Industry Verticals »

All Categories

Insights »

About TMR »

Vertebroplasty and Kyphoplasty Market

Vertebroplasty and Kyphoplasty Market (Product - Vertebroplasty (Needles, Cement Mixing and Delivery Devices), Kyphoplasty (Needles, Balloons, Cement Mixing and Delivery Devices); End use - Hospitals, Ambulatory Surgery Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

The vertebroplasty and kyphoplasty market may experience an upward trend in the forecast period of 2018-2026 because of the increasing preference for minimally invasive surgeries as well as technological advancements in the healthcare sector. In vertebroplasty, bone cement is injected in the vertebra to give support to the specific broken bone. Kyphoplasty is a modified version of vertebroplasty in which a balloon tamp is inflated in the vertebral area for compressing the cancellers bone and form a cavity.

According to studies, a chance of developing back pain in individuals is as high as 80 percent due to various reasons. Changing lifestyle is the main reason for back pains. Sitting without back support and working on computers for a prolonged period accounts for back problems. Thus, with the growing prevalence of back conditions, the vertebroplasty and kyphoplasty market may experience a good growth rate across the forecast period. The COVID-19 outbreak may hardly impact the growth rate of the vertebroplasty and kyphoplasty market as healthcare facilities are open during the lockdown period.

  • Rising cases of vertebral fractures in the young population due to high-velocity injuries while exercising or performing other activities are leaving a positive impact on the growth of the vertebroplasty and kyphoplasty market.
  • Advancements in image-guided surgical procedures are benefiting the vertebroplasty and kyphoplasty market to a great extent. Innovations and development of new technologies based on the research activities carried out by manufacturers in the vertebroplasty and kyphoplasty market are proving to be growth generators for the vertebroplasty and kyphoplasty market. Frequent mergers and acquisitions may bring a positive impact on the growth rate of the vertebroplasty and kyphoplasty market.
  • Geographically, North America is estimated to carry its dominant streak of growth across the forecast period owing to the increased adoption of technologically advanced products and high prevalence of orthopedic disorders.
  • According to Transparency Market Research’s latest report on the global vertebroplasty and kyphoplasty market for the historical period 2017–2018 and forecast period 2019–2027, rise in geriatric population, increase in health care infrastructure globally, and increase in patient compliance due to technical advancements are some factors driving the market.
  • According to the report, the global vertebroplasty and kyphoplasty market was valued at US$ 1.0 Bn in 2018 and is anticipated to expand at a CAGR of 4.6% from 2019 to 2027.
new fa global vertebroplasty kyphoplasty market

Surge in adoption of technologically advanced products: A Key Driver

  • Large number of global manufacturers who have technical expertise and core competencies are undertaking constant efforts to develop and manufacture novel vertebroplasty and kyphoplasty products to attract more customers. Improved biomaterial based implants offering high strength and no leaks of cement during fixing in spine fracture are witnessing an exponential rise in demand in developed as well as developing countries. Affordability, ease of utility, and novelty are the key factors focused upon by product developers in this field to cater to the increasing demand for affordable care among the rapidly growing population affected by spine fracture.
  • Technological advancements in the fields of vertebroplasty and kyphoplasty have brought about significant changes in health care treatments of different vertebral compression fractures. Technological advancements and improvements in vertebroplasty and kyphoplasty equipment have boosted the demand for the kyphoplasty procedure and vertebroplasty in developed as well as emerging economies, especially in the field of surgery. Rise in preference of minimally invasive surgeries is boosting the demand for vertebroplasty and kyphoplasty procedures.
  • Developments in the medical devices industry have enabled the reconstruction of different equipment such as Crosstrees Medical, Inc.’s PVA Pod System, a novel bone cement delivery technology that does not require an implanted device in the spine. Since June 2018, Medtronic’s Khphon bone cement has been available with a new indication for the use of sacral vertebral fracture. Increase in new applications of existing devices and development of new devices are driving the utilization of vertebroplasty and kyphoplasty equipment in the health care industry. These equipment are used to perform different surgeries of spine. This is propelling the vertebroplasty and kyphoplasty market.

High cost of treatment to Hamper Global Vertebroplasty and Kyphoplasty Market

  • The cost of spinal surgeries is significantly high and might not include insurance coverage in certain cases. This leads to an increase in burden on the patient and family, making it unaffordable for people in the low income group. For instance, the cost of lumbar fusion spine surgery in the U.S. is over US$ 45,000 which does not include the cost of imaging, diagnostics, medications, hospital care, and rehabilitation services, among others.
  • In certain cases where the surgery is not covered by health insurance, cost of spinal fusion used for the treatment of slipped vertebra, fractured vertebra, or other spinal instability ranges from US$ 80,000 to US$ 150,000, where high-end titanium implants are used.
  • An article published by Washington Post October 2013, stated that the number of spinal fusion surgeries have increased by 600% to 700% since 2000, and the cost of surgery has tripled due to high cost of the hardware being implanted
  • High cost of surgeries is likely to hamper the growth of the vertebroplasty and kyphoplasty market during the forecast period.

North America to Account for Major Share of Global Vertebroplasty and Kyphoplasty Market

  • North America leads the global vertebroplasty and kyphoplasty market commanding more than 40% share in the global vertebroplasty and kyphoplasty market. Recent advances in vertebroplasty and kyphoplasty products, reimbursement, and improved access to treatment are the major drivers of the vertebroplasty and kyphoplasty market in North America.  U.S. is expected to hold major share in the North America vertebroplasty and kyphoplasty market during the forecast period, owing to developed health care infrastructure in the region and large patient population along with increasing technological development.
  • The vertebroplasty and kyphoplasty market in Asia Pacific is projected to expand at a relatively high growth rate during the forecast period, owing to an increase in focus on the development of health care infrastructure by the public as well as private hospitals, along with an increase in demand for affordable care from a significant base of the patient population. According to the Japan Osteoporosis Society 2015, around 12.8 million people in Japan have osteoporosis, and the incidence of vertebral compression fracture (OVCF) has been steadily increasing with a rise in the number of patients with osteoporosis.

Global Vertebroplasty and kyphoplasty Market: Competitive Landscape

  • This report profiles major players in the global vertebroplasty and kyphoplasty market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Key players operating in the global vertebroplasty and kyphoplasty market include Medtronic, DePuy Synthes (Johnson & Johnson), Alphatec Spine, Inc., Stryker Corporation, Globus Medical, Inc., Merit Medical Systems, Inc., SPINUS (BMK Global Medical Company), IZI Medial Products, Zavation, and RONTIS.
  • Several major manufacturers are collaborating, partnering, acquiring emerging market entrants having novel products. This amalgamation of technical expertise of key players and novel product techniques or materials of new players has ensured launch of new products with improved functionalities in the next few years.
  • In March 2017, Stryker received FDA clearance for its AVAflex balloon system to treat vertebral compression fractures. The company bought this technology from BD. The system mixes, transfers, and primes bone cement for delivery in less then 60 seconds through a single incision.
  • These advanced products that offer advantages such as reduced post-operative complications are rapidly gaining momentum in terms of demand among end-users. This is likely to drive the market during the forecast period.

Global Vertebroplasty and kyphoplasty Market: Key Developments

Players in the vertebroplasty and kyphoplasty market are focused on investing in research and development to develop newer devices with enhanced technology which would enable surgeons to perform the process with ease and enhance the healing process for patients. This would help the companies to strengthen their market positions.

  • In June 2018, Medtronic received the FDA approval to use its Kyphon HV-R bone cement in the sacral vertebral body using sacral vertebroplasty or sacroplasty. This will enable the company to strengthen its leadership position in the kyphoplasty device market..

The report on the global vertebroplasty and kyphoplasty market discusses individual strategies followed by company profiles of manufacturers of vertebroplasty and kyphoplasty treatment products. The competitive landscape section has been included in the vertebroplasty and kyphoplasty market report to provide readers with a dashboard view and a company vertebroplasty and kyphoplasty market share analysis of key players operating in the global vertebroplasty and kyphoplasty market.

Global Vertebroplasty and Kyphoplasty Market – Segmentation

Product

Vertebroplasty

  • Needles
  • Cement Mixing & Delivery Devices

Kyphoplasty

  • Needles & Balloons
  • Cement Mixing & Delivery Devices
  • Recombinant Polyclonal Antibodies

End-user

Hospitals

Ambulatory Surgery Centers

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of vertebroplasty and kyphoplasty market?

The global vertebroplasty and kyphoplasty market was worth US$ 1.0 Bn and is projected to reach a value of US$ 1.5 Bn by the end of 2027

What is the anticipated CAGR of the vertebroplasty and kyphoplasty market in the forecast period?

Vertebroplasty and kyphoplasty market is anticipated to grow at a CAGR of 4.6% during the forecast period

Which region is expected to project the highest market share in the global vertebroplasty and kyphoplasty market?

North America accounted for a major share of the global vertebroplasty and kyphoplasty market

What are the key driving factors for the growth of the vertebroplasty and kyphoplasty market?

Vertebroplasty and Kyphoplasty market is driven by increase in demand for Technological advancements and improvements in vertebroplasty and kyphoplasty equipment

Who are the key players in the global vertebroplasty and kyphoplasty market?

Key players in the global vertebroplasty and kyphoplasty market include Medtronic, DePuy Synthes (Johnson & Johnson), Alphatec Spine, Inc., Stryker Corporation, Globus Medical, Inc., Merit Medical Systems, Inc., SPINUS (BMK Global Medical Company), IZI Medial Products, Zavation, and RONTIS

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Vertebroplasty and Kyphoplasty Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Vertebroplasty and Kyphoplasty Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Market Outlook

        5.1. Reimbursement Scenario

        5.2. Technological Advancements

        5.3. Key Mergers & Acquisitions 

        5.4. Price Comparison Analysis (2017), by Product Type

    6. Global Vertebroplasty and Kyphoplasty Market Analysis and Forecast, by Product 

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2027

            6.3.1. Vertebroplasty

                6.3.1.1. Needles

                6.3.1.2. Cement Mixing & Delivery Device

            6.3.2. Kyphoplasty

                6.3.2.1. Needles & Balloons

                6.3.2.2. Cement Mixing and delivery Device

        6.4. Market Attractiveness, by Product 

    7. Global Vertebroplasty and Kyphoplasty Market Analysis and Forecast, by End-user 

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by End-user, 2017–2027

            7.3.1. Hospitals

            7.3.2. Ambulatory Surgery Centers

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Vertebroplasty and Kyphoplasty Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. Market Attractiveness Analysis, by Region

    9. North America Vertebroplasty and Kyphoplasty Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast By Product, 2017–2027

            9.2.1. Vertebroplasty

                9.2.1.1. Needles

                9.2.1.2. Cement Mixing & Delivery Device

            9.2.2. Kyphoplasty

                9.2.2.1. Needles & Balloons

                9.2.2.2. Cement Mixing and delivery Device

        9.3. Market Value Forecast, by End-user, 2017–2027

            9.3.1. Hospitals

            9.3.2. Ambulatory Surgery Centers

        9.4. Market Value Forecast, by Country, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis 

            9.5.1. By Product 

            9.5.2. By End-user 

            9.5.3. By Country

    10. Europe Vertebroplasty and Kyphoplasty Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2017–2027

            10.2.1. Vertebroplasty

                10.2.1.1. Needles

                10.2.1.2. Cement Mixing & Delivery Device

            10.2.2. Kyphoplasty

                10.2.2.1. Needles & Balloons

                10.2.2.2. Cement Mixing and delivery Device

        10.3. Market Value Forecast, by End-user, 2017–2027

            10.3.1. Hospitals

            10.3.2. Ambulatory Surgery Centers

        10.4. Market Value Forecast, by Country/Sub-region, 2017–2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis 

            10.5.1. By Product 

            10.5.2. By End-user 

            10.5.3. By Country/Sub-region

    11. Asia Pacific Vertebroplasty and Kyphoplasty Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2027

            11.2.1. Vertebroplasty

                11.2.1.1. Needles

                11.2.1.2. Cement Mixing & Delivery Device

            11.2.2. Kyphoplasty

                11.2.2.1. Needles & Balloons

                11.2.2.2. Cement Mixing and delivery Device

        11.3. Market Value Forecast, by End-user, 2017–2027

            11.3.1. Hospitals

            11.3.2. Ambulatory Surgery Centers

        11.4. Market Value Forecast, by Country/Sub-region, 2017–2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis 

            11.5.1. By Product 

            11.5.2. By End-user 

            11.5.3. By Country/Sub-region

    12. Latin America Vertebroplasty and Kyphoplasty Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2027

            12.2.1. Vertebroplasty

                12.2.1.1. Needles

                12.2.1.2. Cement Mixing & Delivery Device

            12.2.2. Kyphoplasty

                12.2.2.1. Needles & Balloons

                12.2.2.2. Cement Mixing and delivery Device

        12.3. Market Value Forecast, by End-user, 2017–2027

            12.3.1. Hospitals

            12.3.2. Ambulatory Surgery Centers

        12.4. Market Value Forecast, by Country/Sub-region, 2017–2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis 

            12.5.1. By Product 

            12.5.2. By End-user 

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Vertebroplasty and Kyphoplasty Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2027

            13.2.1. Vertebroplasty

                13.2.1.1. Needles

                13.2.1.2. Cement Mixing & Delivery Device

            13.2.2. Kyphoplasty

                13.2.2.1. Needles & Balloons

                13.2.2.2. Cement Mixing and delivery Device

        13.3. Market Value Forecast, by End-user, 2017–2027

            13.3.1. Hospitals

            13.3.2. Ambulatory Surgery Centers

        13.4. Market Value Forecast, by Country/Sub-region, 2017–2027

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis 

            13.5.1. By Product 

            13.5.2. By End-user 

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (By Tier and Size of companies)

        14.2. Market Share/Position Analysis, by Company, 2018

        14.3. Company Profiles

            14.3.1. Medtronic

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Growth Strategies

                14.3.1.3. SWOT Analysis

            14.3.2. DePuy Synthes (Johnson & Johnson) 

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Growth Strategies

                14.3.2.3. SWOT Analysis

            14.3.3. Alphatec Spine, Inc.

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Growth Strategies

                14.3.3.3. SWOT Analysis

            14.3.4. Stryker Corporation

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Growth Strategies

                14.3.4.3. SWOT Analysis

            14.3.5. Globus Medical, Inc.

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Growth Strategies

                14.3.5.3. SWOT Analysis

            14.3.6. Merit Medical Systems, Inc.

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Growth Strategies

                14.3.6.3. SWOT Analysis

            14.3.7. SPINUS (BMK Global Medical Company) 

                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Growth Strategies

                14.3.7.3. SWOT Analysis

            14.3.8. IZI Medial Products  

                14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Growth Strategies

                14.3.8.3. SWOT Analysis

            14.3.9. Zavation  

                14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.9.2. Growth Strategies

                14.3.9.3. SWOT Analysis

            14.3.10. RONTIS  

                14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.10.2. Growth Strategies

                14.3.10.3. SWOT Analysis

    List of Tables

    Table 01: Key Mergers & Acquisition in the Vertebroplasty and Kyphoplasty Market

    Table 02: Global Vertebroplasty and Kyphoplasty Size (US$ Mn) Forecast, by Products, 2017–2027

    Table 03: Global Vertebroplasty and Kyphoplasty Size (US$ Mn) Forecast, by Products, (Vertebroplasty) 2017–2027

    Table 04: Global Vertebroplasty and Kyphoplasty Size (US$ Mn) Forecast, by Products, (Kyphoplasty) 2017–2027

    Table 05: Global Vertebroplasty and Kyphoplasty Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 06: Global Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 07: North America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 08: North America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 09: North America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Vertebroplasty, 2017–2027

    Table 10: North America Vertebroplasty and kyphoplasty Market Value (US$ Mn) Forecast, by Kyphoplasty, 2017–2027

    Table 11: North America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 12: Europe Gram-Positive Bacterial Infections Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 13: Europe Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 14: Europe Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product (Vertebroplasty), 2017–2027

    Table 15: Europe Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product (Kyphoplasty), 2017–2027

    Table 16: Europe Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 17: Asia Pacific Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 18: Asia Pacific Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 19: Asia Pacific Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product(Vertebroplasty), 2017–2027

    Table 20: Asia Pacific Vertebroplasty and Kyphoplastys Market Value (US$ Mn) Forecast, by Product(Kyphoplasty), 2017–2027

    Table 21: Asia Pacific Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 22: Latin America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 23: Latin America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 24: Latin America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product(Vertebroplasty), 2017–2027

    Table 25: Latin America Vertebroplasty and Kyphoplastys Market Value (US$ Mn) Forecast, by Product(Kyphoplasty), 2017–2027

    Table 26: Latin America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 27: Middle East & Africa Gram-Positive Bacterial Infections Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 28: Middle East & Africa Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product, 2017–2027

    Table 29: Middle East & Africa Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by Product(Vertebroplasty), 2017–2027

    Table 30: Middle East & Africa Vertebroplasty and Kyphoplastys Market Value (US$ Mn) Forecast, by Product(Kyphoplasty), 2017–2027

    Table 31: Middle East & Africa Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    List of Figures

    Figure 01: Global Vertebroplasty and Kyphoplasty Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027

    Figure 02: Market Snapshot of Global Vertebroplasty and Kyphoplasty Market 

    Figure 03: Market Opportunity Map, Revenue Share, by Product

    Figure 04: Market Opportunity Map, Revenue Share, by End-user

    Figure 05: Global Vertebroplasty and Kyphoplasty Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 06: Global Vertebroplasty and Kyphoplasty Market Value Share, by Product Type (2017)

    Figure 07: Global Vertebroplasty and Kyphoplasty Market Value Share, by End-user (2017)

    Figure 08: Global Vertebroplasty and Kyphoplasty Market Value Share, by Region (2017)

    Figure 09: Global Vertebroplasty and Kyphoplasty Market Value Share Analysis, by product, 2018 and 2027

    Figure 10: Global Vertebroplasty and Kyphoplasty Market Value Share Analysis, by product, (Vertebroplasty) 2018 and 2027

    Figure 11: Global Vertebroplasty and Kyphoplasty Market Value Share Analysis, by product, (Kyphoplasty) 2018 and 2027

    Figure 12: Global Vertebroplasty and Kyphoplasty Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vertebroplasty 2017–2027

    Figure 13: Global Vertebroplasty and Kyphoplasty Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Kyphoplasty, 2017–2027

    Figure 14: Global Vertebroplasty and Kyphoplasty Market Attractiveness, by Product, 2018–2027

    Figure 15: Global Vertebroplasty and Kyphoplasty Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 16: Global Vertebroplasty and Kyphoplasty Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2027

    Figure 17: Global Vertebroplasty and Kyphoplasty Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers , 2017–2027

    Figure 18: Global Vertebroplasty and Kyphoplasty Market Attractiveness, by End-user, 2018–2027

    Figure 19: Global Vertebroplasty and Kyphoplasty Market Value Share (%), by Region, 2018 and 2027

    Figure 20: Global Vertebroplasty and Kyphoplasty Market Attractiveness, by Region, 2018–2027

    Figure 21: North America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 22: North America Vertebroplasty and Kyphoplasty Market Value Share, by Country, 2018 and 2027

    Figure 23: North America Vertebroplasty and Kyphoplasty Market Attractiveness, by Country, 2018–2027

    Figure 24: North America Vertebroplasty and Kyphoplasty Market Value Share, by Product, 2018 and 2027

    Figure 25: North America Vertebroplasty and Kyphoplasty Market Attractiveness, by Product, 2018–2027

    Figure 26: North America Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Vertebroplasty, 2018 and 2027

    Figure 27: North America Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Kyphoplasty, 2018 and 2027

    Figure 28: North America Vertebroplasty and Kyphoplasty Market Value Share, by End-user, 2018 and 2027

    Figure 29: North America Vertebroplasty and Kyphoplasty Market Attractiveness, by End-user, 2018–2027

    Figure 30: Europe Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 31: Europe Vertebroplasty and Kyphoplasty Market Value Share, by Country/Sub-region, 2018 and 2027

    Figure 32: Europe Vertebroplasty and Kyphoplasty Market Attractiveness, by Country/Sub-region, 2018–2027

    Figure 33: Europe Vertebroplasty and Kyphoplasty Market Value Share, by Product, 2018 and 2027

    Figure 34: Europe Vertebroplasty and Kyphoplasty Market Attractiveness, by Product, 2018–2027

    Figure 35: Europe Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Product (Vertebroplasty), 2018 and 2027

    Figure 36: Europe Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Product (Kyphoplasty), 2018 and 2027

    Figure 37: Europe Vertebroplasty and Kyphoplasty Market Value Share, by End-user, 2018 and 2027

    Figure 38: Europe Vertebroplasty and Kyphoplasty Market Attractiveness, by End-user, 2018–2027

    Figure 39: Asia Pacific Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 40: Asia Pacific Vertebroplasty and Kyphoplasty Market Value Share, by Country/Sub-region , 2018 and 2027

    Figure 41: Asia Pacific Vertebroplasty and Kyphoplasty Market Attractiveness, by Country/Sub-region, 2018 and 2026

    Figure 42: Asia Pacific Vertebroplasty and Kyphoplasty Market Value Share, by Product, 2018 and 2027

    Figure 43: Asia Pacific Vertebroplasty and Kyphoplasty Market Attractiveness, by Product, 2018–2027

    Figure 44: Asia Pacific Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Product(Vertebroplasty), 2018 and 2027

    Figure 45: Asia Pacific Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Product(Kyphoplasty), 2018 and 2027

    Figure 46: Asia Pacific Vertebroplasty and Kyphoplasty Market Value Share, by End-user, 2018 and 2027

    Figure 47: Asia Pacific Vertebroplasty and Kyphoplasty Market Attractiveness, by End-user, 2018–2027

    Figure 48: Latin America Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 49: Latin America Vertebroplasty and Kyphoplasty Market Value Share, by Country/Sub-region, 2018 and 2027

    Figure 50: Latin America Vertebroplasty and Kyphoplasty Market Attractiveness, by Country/Sub-region, 2018 and 2026

    Figure 51: Latin America Vertebroplasty and Kyphoplasty Market Value Share, by Product, 2018 and 2027

    Figure 52: Latin America Vertebroplasty and Kyphoplasty Market Attractiveness, by Product, 2017–2026

    Figure 53: Latin America Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Product(Vertebroplasty), 2018 and 2027

    Figure 54: Latin America Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Product(Kyphoplasty), 2018 and 2027

    Figure 55: Latin America Vertebroplasty and Kyphoplasty Market Value Share, by End-user, 2018 and 2027

    Figure 56: Latin America Vertebroplasty and Kyphoplasty Market Attractiveness, by End-user, 2017–2026

    Figure 57: Middle East & Africa Vertebroplasty and Kyphoplasty Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 58: Middle East & Africa Vertebroplasty and Kyphoplasty Market Value Share, by Country/Sub-region, 2018 and 2027

    Figure 59: Middle East & Africa Vertebroplasty and Kyphoplasty Market Attractiveness, by Country/Sub-region, 2018 and 2026

    Figure 60: Middle East & Africa Vertebroplasty and Kyphoplasty Market Value Share, by Product, 2018 and 2027

    Figure 61: Middle East & Africa Vertebroplasty and Kyphoplasty Market Attractiveness, by Product, 2017–2026

    Figure 62: Middle East & Africa Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Product(Vertebroplasty), 2018 and 2027

    Figure 63: Middle East & Africa Vertebroplasty and Kyphoplasty Market Value Share Analysis, by Product(Kyphoplasty), 2018 and 2027

    Figure 64: Middle East & Africa Vertebroplasty and Kyphoplasty Market Value Share, by End-user, 2018 and 2027

    Figure 65: Middle East & Africa Vertebroplasty and Kyphoplasty Market Attractiveness, by End-user, 2017–2026

    Figure 66: Medtronic, Revenue (US$ Mn), 2015–2017

    Figure 67: Medtronic, Sales by Region (2017)

    Figure 68: Medtronic, R&D Expenditure (US$ Mn), 2015–2017

    Figure 69: Medtronic Spine Segment, Revenue (US$ Mn), 2016–2017

    Figure 70: Johnson & Johnson, Orthopedics Franchise of Medical Device Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

    Figure 71: Johnson & Johnson, Breakdown of Net Sales (%), by Geography, 2017

    Figure 72: Johnson & Johnson, R&D Expenditure (US$ Mn), 2015–2017

    Figure 73: Johnson & Johnson ,Spine & Other Segment, Revenue (US$ Mn), 2016–2017

    Figure 74: Alphatec Spine, Inc.,  Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

    Figure 75: Alphatec Spine, Inc., Breakdown of Net Sales (%), by Geography, 2017

    Figure 76: Alphatec Spine, Inc., R&D Expenditure (US$ Mn), 2015–2017

    Figure 77: Alphatec Spine, Inc., Sales and Marketing Expenditure (US$ Mn), 2015–2017

    Figure 78: Stryker Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

    Figure 79: Stryker Corporation,  Research, and Development Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017

    Figure 80: Stryker Corporation, Breakdown of Net Sales (%), by Geography, 2017

    Figure 81: Styker Corporation, Breakdown of Net Sales (%), by Business Segment, 2017

    Figure 82: Globus Medical Inc.,  Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

    Figure 83: Globus Medical Inc., Breakdown of Net Sales (%), by Geography, 2017

    Figure 84: Globus Medical Inc., R&D Expenditure (US$ Mn), 2015–2017

    Figure 85: Globus Medical Inc., Breakdown of Net Sales (%), by Business Segment, 2017

    Figure 86: Merit Medical Systems, Inc.,  Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

    Figure 87: Merit Medical Systems, Inc., Breakdown of Net Sales (%), by Geography, 2017

    Figure 88: Merit Medical Systems, Inc., R&D Expenditure (US$ Mn), 2015–2017

    Figure 89: Merit Medical Systems, Inc., Breakdown of Net Sales (%), by Business Segment-Cardiovascular, 2017

Copyright © Transparency Market Research, Inc. All Rights reserved

Vertebroplasty and Kyphoplasty Market

Schedule a Call